Jianqin Lu, BPharm, PhD


Dr. Lu obtained his Ph.D. at the University of Pittsburgh in 2014 and then performed postdoctoral training on nanomedicine and tumor immunology at the University of Chicago and UCLA. He joined the University of Arizona as an Assistant Professor of Pharmaceutical Sciences in 2019. His research has been supported by the NIH/NIGMS Maximizing Investigators' Research Award (MIRA) (R35), the NIH/NCI R01, Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Faculty Starter Grant in Drug Delivery, and the State of Arizona's Technology and Research Initiative Fund (TRIF)/BIO5 Institute as well as The Southwest Environmental Health Sciences Center (SWEHSC). Dr. Lu serves as the Director of the Pharmaceutics and Pharmacokinetics Track at the R. Ken Coit College of Pharmacy and the Associate Editor for Frontiers in Medical Technology: Nano-Based Drug Delivery.

Cancer Focus

Dr. Lu’s lab strives to develop innovative, safe, and efficacious nanotherapeutics at the interface of drug delivery, synthetic chemistry, molecular pharmaceutics, nanoengineering, and tumor immunology to address the pressing unmet needs in colorectal cancer, pancreatic cancer, breast cancer, melanoma, and lymphoma.
Research Program Role
Clinical and Translational Oncology Program

Display Name
Jianqin Lu, BPharm, PhD